Document is current
Any future updates will be listed below
-
Authors
Tremblay, Douglas
Mesa, Ruben https://orcid.org/0000-0001-5880-7972
- License Information
-
More Information
Article History
Received: 11 January 2022
Revised: 24 January 2022
Accepted: 24 January 2022
First Online: 19 February 2022
Declarations
:
: Douglas Tremblay receives contracted research funding paid to his institution from Astellas Pharma and consulting fees from AbbVie and CTI Biopharma. Ruben Mesa receives contracted research funding paid to his institution from Celgene, Incyte, Abbvie, Samus, Genotech, Promedior, CTI Biopharma, Constellation and the Mays Cancer Center P30 Cancer Center Support Grant from the National Cancer Institute (CA054174). He receives consulting fees from Novartis, Sierra Oncology, LaJolla Pharmaceutical, and Constellation.
